Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Tags:
Funding Products

Losartan 12.5mg among 12 price concessions agreed for July

  • News

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 12 items for July 2019 prescriptions.

Drug
Strength
Form
Price
Betahistine
8mg
tablets (84)
£1.37
Betahistine
16mg
tablets (84)
£2.50
Ibandronic acid
150mg
tablets (1)
£9.95
Losartan
12.5mg
tablets (28)
£3.82
Pantoprazole
40mg
gastro-resistant tablets (28)
£3.85
Prednisolone
5mg
tablets (28)
£2.25
Prednisolone sodium phosphate
0.5%
ear/eye drops (10ml)
£2.49
Risedronate sodium
35mg
tablets (4)
£11.68
Tamoxifen
20mg
tablets (30)
£3.40
Tolbutamide
500mg
tablets (28)
£17.25
Valsartan
160mg
capsules (28)
£14.99
Valsartan/ hydrochlorothiazide
160mg/12.5mg
tablets (28)
£8.90
Table

View full table

Do these prices reflect the ones you have paid in July so far?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Tags:
Funding Products
Latest News & Analysis

Stop smoking: 10% rise in people seeking to quit in pharmacies

Community pharmacist named new Cegedim Rx UK managing director

Turning over a new leaf

Opinion: Even the cleverest analysis will only prolong the medicine shortage

See All
UsernamePublicRestriction

Register

CD005995

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By